

During an April 17 congressional hearing, Health and Human Services Secretary Robert F. Kennedy Jr. called for retraction of a new Danish study that didn’t find a link between Tylenol and autism, repeatedly calling it “garbage” and baselessly suggesting that it was industry-generated and “fraudulent.” There is no evidence of fraud or industry involvement, and the criticism Kennedy made was a limitation the authors of the paper acknowledged — not legitimate grounds for retraction, according to scientists. Beginning with a press conference about autism in September — the Kennedy-imposed deadline for knowing the cause of the “autism epidemic” — President Donald Trump has repeatedly told pregnant women not to take Tylenol unless “absolutely necessary.” Kennedy has been a bit more circumspect on the topic, speaking of a “potential association” between prenatal Tylenol, also known as acetaminophen, and later autism diagnoses in children and calling the literature finding a connection “very suggestive.” As we wrote in September, some studies have shown an association between prenatal acetaminophen use and autism. However, experts told us that these associations were likely not causal, and instead probably due to traits shared among people who tend to take more acetaminophen in pregnancy, such as a hereditary
Lean: -0.200 · Source quality 85/100 · Factual vs opinion 80/100.
© 2026 Vistoa. All rights reserved.
Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.